FDA Approves PIRFENIDONE — Aurobindo Pharma Limited

# FDA Approves Generic Pirfenidone from Aurobindo Pharma The FDA has approved Aurobindo Pharma Limited's generic version of pirfenidone, an oral antifibrotic treatment for idiopathic pulmonary fibrosis, potentially expanding patient access while intensifying competition in a market previously dominated by branded alternatives. The approval could drive significant price reductions and increase market penetration for this specialty pharmaceutical, benefiting both payers and patients requiring long-term IPF management.